All research
Oxytocin 2022-06-29 ClinicalTrials

Intranasal Oxytocin Investigated to Reduce Heavy Drinking Days in Alcohol Use Disorder

Intranasal Oxytocin for the Treatment of Alcohol Use Disorder

Abstract

Intranasal oxytocin is being investigated for its efficacy in reducing weekly heavy drinking days in patients with moderate to severe Alcohol Use Disorder.


Source: clinicaltrials:NCT03878316 · Ingested 2026-06-09 · Digest: gemini-2.5-flash